RejuvenAir Cryospray for Treating COPD with Chronic Bronchitis Going on Trial
The FDA has just issued a Breakthrough Device designation and an Investigational Device Exemption (IDE) to CSA Medical for its RejuvenAir system as a treatment option for patients with moderate to severe chronic obstructive pulmonary disease (COPD) ...
Source: Medgadget - Category: Medical Devices Authors: Editors Tags: Medicine Thoracic Surgery Source Type: blogs
More News: Bronchitis | Cardiovascular & Thoracic Surgery | Chronic Obstructive Pulmonary | Medical Devices | Study